• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Roche picks up a speedy nod in Chi­na as reg­u­la­tors fol­low through on plans for a fast 48 new drug OKs

7 years ago
China
Pharma

Pfiz­er spells out PhI­II ta­la­zoparib da­ta in NE­JM ar­ti­cle; Tolero teams up with Ab­b­Vie for AML com­bo

7 years ago
News Briefing

Out­spo­ken re­searcher Pe­ter Bach urges CMS to con­sid­er ways of bring­ing down CAR-T prices — and of­fers a few ...

7 years ago
Pharma

John Kaiser finds next CEO role at Duke spin­out Evecx­ia; Im­muno­core vet Namir Has­san moves to I/O biotech Zel­lu­na

7 years ago
Peer Review

Just a few days af­ter a stum­ble, FDA OKs 12-week dose for Eylea as Re­gen­eron braces for No­var­tis at­tack

7 years ago
Pharma

In a land­mark OK, FDA green-lights Bris­tol-My­er­s' Op­di­vo for a niche group of metasta­t­ic lung can­cer pa­tients

7 years ago
Pharma

FDA, NIH look to stream­line over­sight of gene ther­a­pies

7 years ago
Pharma
Cell/Gene Tx

No­vo Nordisk buys uni­ver­si­ty spin­out Ziy­lo — adding a po­ten­tial rem­e­dy for hy­po­glycemia to its di­a­betes pipeline

7 years ago
Deals

Months af­ter team­ing up on RTK in­hibitor Lenvi­ma, Ei­sai/Mer­ck win new FDA OK in liv­er can­cer

7 years ago
Pharma

Af­ter a years-long de­lay, FDA ap­proves first gener­ic ver­sions of EpiPen

7 years ago
Pharma

Sarep­ta CEO Doug In­gram buys $2M batch of his biotech's stock; Ex­press Scripts ex­plor­ing ex­clu­sive gene ther­a­py deals

7 years ago
News Briefing

For­mer head of Chi­na's FDA boot­ed in wake of sear­ing vac­cine scan­dal as lead­ers im­pose 'se­vere pun­ish­men­t'

7 years ago
R&D
China

No more hands-off Roche su­per­vi­sion? Genen­tech brings out the axe, slash­ing 223 HQ staffers 'across de­part­ments'

7 years ago
R&D
Pharma

'Gap years' are for adults, too: Ex-Foun­da­tion ex­ec Steve Kaf­ka joins Third Rock af­ter glo­be­trot­ting break

7 years ago
People

A 'high-risk, high-re­ward' ef­fort on NGF pain med fas­inum­ab by Re­gen­eron, Te­va clears a re­vised PhI­II -- se­ri­ous ...

7 years ago
R&D

Bio­haven steps up big clin­i­cal plans for its re­for­mu­lat­ed ALS gener­ic — now al­so aimed at anx­i­ety

7 years ago
R&D

Pfiz­er hits the gas ped­al in the mR­NA flu vac­cine de­vel­op­ment race, ink­ing a $425M in­vest­ment pact with BioN­Tech

7 years ago
Pharma

Ar­mored CAR-Ts? Memo­r­i­al Sloan Ket­ter­ing en­gi­neers CAR-T loaded with check­point in­hibitors

7 years ago
Discovery

Let's go to Chi­na: Join End­points in Shang­hai for the first US-Chi­na Bio­phar­ma In­no­va­tion & In­vest­ment Sum­mit — ...

7 years ago
Publisher's note
China

Der­ma­tol­ogy biotech Blue­ber­ry Ther­a­peu­tics banks $12M Se­ries B — and new part­ners in Asia

7 years ago
Financing

Black­stone in­vests $400M in one of Chi­na's fast-grow­ing phar­ma com­pa­nies; CVS sets up an ICER-based for­mu­la­ry

7 years ago
News Briefing

Eyes on Chi­na stocks: Lon­car loads new ETF with his picks for most promis­ing biotechs on HKEX and Nas­daq

7 years ago
China
Pharma

Back in busi­ness af­ter a spell in lim­bo, Iron­shore says it has raised $143M for AD­HD drug roll­out

7 years ago
Pharma

The biotech mood at the halfway mark of 2018? Bois­ter­ous, fo­cus­ing more at­ten­tion on Chi­na and look­ing for ...

7 years ago
Special
First page Previous page 1003100410051006100710081009 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.